{
    "root": "47119208-bd76-47ac-9768-b044d893952c",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "IBSRELA",
    "value": "20250122",
    "ingredients": [
        {
            "name": "TENAPANOR HYDROCHLORIDE",
            "code": "50605O2ZNS"
        }
    ],
    "indications": "IBSRELA is indicated for treatment of irritable bowel syndrome with constipation (IBS-C) in adults.",
    "contraindications": "The recommended dosage of IBSRELA in adults is 50 mg orally twice daily.",
    "warningsAndPrecautions": "IBSRELA tablets contain 50 mg tenapanor and are oval, white to off-white, debossed with \"50\" on one side and \"5791\" on the other side.\n                  IBSRELA is supplied in a white, opaque, high-density polyethylene bottle containing 60 tablets with a silica gel canister (as the desiccant) and screw-top polypropylene child-resistant cap lined and induction-activated aluminum foil liner (NDC 73154-050-60).",
    "adverseReactions": "IBSRELA is contraindicated in:\n                  \n                     Patients less than 6 years of age due to the risk of serious dehydration [see Warnings and Precautions (5.1), Use in Specific Populations (8.4)].\n                     \n                     Patients with known or suspected mechanical gastrointestinal obstruction."
}